PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Phio Pharmaceuticals Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.87−0.00 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $10.09M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Phio Pharmaceuticals has not reported a dividend
No dividend per share appears in Phio Pharmaceuticals's annual filings since fiscal 2010.